Our Team

The CPI team has a mix of research skills and experience across a number of domains. These include high-quality and internationally competitive scientific achievement, leading-edge technical expertise, proven capacity to modify clinical practice, high achievement in medical and postgraduate education, professional leadership and record of translation. An example of the latter is the development of novel reagents to inhibit kidney damage, which have been patented (Alexander) and are moving ahead with further studies for potential comercialisation. The team will be supported by researchers with internationally recognized expertise in relevant scientific techniques, commercialization, and personalized therapeutics.